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Abstract
Objective: This paper intends to report our experiences by using an operation of off-pump occlusion of trans-
thoracic minimal invasive surgery (OPOTTMIS) on the treatment of consecutive 210 patients with simple congenital
heart diseases (CHD) including atrial septal defect (ASD), ventricular septal defect (VSD) and patent ductus
arteriosus (PDA).
Methods: The retrospective clinical data of OPOTTMIS in our institute were collected and compared to other
therapeutic measures adopted in the relevant literatures. After operation, all the patients received
electrocardiography (ECG) and echocardiography (echo) once a month within the initial 3 months, and no less
than once every 3 ~ 6 months later.
Results: The successful rate of the performed OPOTTMIS operation was 99.5%, the mortality and complication
incidence within 72 hours were 0.5% and 4.8%, respectively. There were no major complications during peri-
operation such as cardiac rupture, infective endocarditis, strokes, haemolysis and thrombosis. The post-operation
follow-up outcomes by ECG and echo checks of 3 months to 5 years showed that there were no III° AVB, no
obvious Occluder migration and device broken and no moderate cardiac valve regurgitation, except 1 VSD and 1
PDA with mild residual shunts, and 2 PDA with heart expansion after operation. However, all the patients’ heart
functions were in class I~II according to NYH standard.
Conclusion: The OPOTTMIS is a safe, less complex, feasible and effective choice to selected simple CHD patients
with some good advantages and favorable short term efficacies.
Keywords: Off-pump Occlusion, Minimal invasive surgery, Congenital Heart Disease, Trans-esophageal
Echocardiography
Backgrounds
Congenital heart diseases (CHD) are common com-
plaints with incidence of 8‰ ~1 2 ‰ in China, including
atrial septal defect (ASD), ventricular septal defect
(VSD) and patent ductus arteriosus (PDA). Approxi-
mately, there are 150,000 ~ 200,000 Chinese infants
born with CHD every year [1]. Now days, there are dif-
ferent treatment methods to CHD as traditional open
surgery, physician interventional occlusion through
intravenous catheter delivery system, several minimal
invasive surgery using various small incision, video
assisted thoracoscope, robotic systems, hybrid
approaches, etc. More or less, these methods have their
shortcomings, such as, sever body injuries by extended
open-chest incision and cardiopulmonary bypass (CPB),
many morbidities and complications, long skin scars,
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cure to master the sophisticated procedures, and radia-
tion damages to intervention physicians and patients
that cannot be avoided. Once patients’ venous vessels
and inner cardiac structures were damaged by catheter
and wire due to the long pathway and slender sheath
and wire, then open surgery must be transferred for res-
cue [2-11]. In recent decades, hybrid approaches have
been accepted by people gradually with the rapid devel-
opment of minimal invasive techniques and equipments.
As one technique of hybrid approach, OPOTTMIS has
grown into a safe and effective treatment method for
simple CHD [12-24]. In this article, we reported the
experiences of consecutive 210 cases simple CHD
patients treated with OPOTTMIS in our hospital during
July 2005 ~ October 2010.
Materials and methods
1. Patient information
The consecutive 210 simple CHD patients (96 males
and 104 females) with 3 ~ 56 (18.92 ± 15.64) years of
old and 8.0 ~ 54.5 (24.78 ± 16.63) kilograms of weight,
were diagnosed through physical examination, chest X-
Ray, ECG and echo including trans-thorax echocardio-
graphy (TTE) or/and trans-esophageal echocardiography
(TEE). There were 92 cases of ASD with diameter of
21.5 ± 11.6 mm, 63 cases of VSD with diameter of 9.8 ±
3.2 mm, and 55 cases of PDA with diameter of 7.6 ± 1.8
mm (including 1 cases of adult PDA approach to severe
pulmonary hypertension).
2. Preoperative preparation
The probable risk of OPTTMIS, anaesthesia, blood
transfusion and transformt oo p e ns u r g e r yw i t hC P B
must be informed to the patients and their family mem-
bers. All the patients were asked to sign the informed
consent before operation to accept the treatment with
OPOTTMIS method. Occluders and delivery systems,
ultrasonograph (Mode: PHILIPS 4500) assembled with
sterilized probes for intra-operation TTE and TEE
checks, blood for transfusion, CPB machines and open
operation pertinent equipments must be prepared for
use when needed.
3. Occluders
The special double lumen equipment of delivery systems
for OPOTTMIS are composed by the outer and inner
sheath, delivery rod, retrieval wire, guide probe, and
o c c l u d ed e v i c e( F i g u r e1 )[ 2 4 ] ,a n dt h es h e a t hd i a m e t e r
is Fr 6 ~ Fr 26. The sizes of ASD, VSD and PDA Occlu-
ders (Figure 2) are different from 15 ~ 46 mm, 8 ~ 22
mm and 6 ~ 16 mm, respectively. The experienced for-
mulation of Occluder size selection for OPOTTMIS
were shown (Table 1).
4. Inclusion and exclusion statements
Applications and contraindications of OPOTTMIS for
simple CHD patients were accepted according to the
ACC/AHA 2008 adult CHD administer guidelines [25]
and shown as follows (Table 2, Table 3 and Table 4).
5. The procedure of OPOTTMIS
(1) The patients were placed in the supine position and
administered by inhaled general anesthesia through sin-
gle or double lumen tracheal catheter intubation. The
defect malformations were verified by the TEE checks
through the probes placed into the patients’ esophagus.
(2) As a general rule in most cases, the selected chest
wall incisions of ASD, VSD and PDA were located at
the third or fourth intercostal space right lateral sternal
with 2.0 ~ 3.0 cm in length, distal midterm sternotomy
to xiphoid with 3.0 ~ 5.0 cm in length, and the second
intercostal space of left lateral sternal with 2.0 ~ 3.0 cm
in length, while the selected cardiac puncture sites apart
Figure 1 Delivery systems and self-made devices used for OPOTTMIS. Outer sheath; Inner sheath; Guiding probe; Delivery rod; Retrieval
wire.
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wall, the right ventricular wall with tremor, and the pri-
mary pulmonary arterial wall with obvious thrill,
respectively.
(3) Surgical procedures
①Patients were placed on the operation-table at pros-
trate position with the operation lateral body raised and
sloped to 30° ~ 45° using cushions. Then the selected
chest wall was cut by a scalpel and exposed with a small
rib retractor. After pericardium incision and sling to the
chest wall using gross silk suture, heparin was admini-
strated to the patient by intravenous injection with dose
of 0.5 ~ 1.0 mg/kg. When ACT (accelerated clotting
time) surpassed 200 s, double purse-string suture or
d o u b l eU - s h a p es u t u r ew e r es e w e da tt h es i t eo ft h e
selected cardiac wall using 4/0 Prolene lines attached
with double needles and small Teflon or pericardium
pads.
②The outer self-made delivery sheath and guide
probe were punctured into the appropriate cardiac or
main pulmonary chamber through the central of the
suture. After the guide probe pulled out and a guide
wire put into the outer sheath promptly, the delivery
rod (also named as the inner sheath) was pushed into
the corresponding chamber of the heart along the guide
wire through the defects under TEE surveillance.
③The chosen Occluder with right size was rinsed
within 1% concentration of heparin normal saline
solution for about 5 minutes. Then the guide wire was
pulled out while the Occluder stitched with a safe wire
on it was placed into the inner delivery sheath as soon
as possible to prevent massive bleeding and air entering
into the cardiac or main pulmonary chambers. Under
the surveillance of ECG and TEE checks (TTE or trans-
epicardium echo when needed), the “push-pull” test was
performed to adjust the position of the Occluder release
and ensure that its waist will straddle on the edges of
the defects firmly and well, and there were no moderate
to heavy residual shunts, no atrioventricular and semilu-
nar valves influences, no III° AVB and no massive air in
cardiac chambers. After that, the delivery sheath and the
safe wire were cut off and pulled out of the heart, then
the double purse-string or double U-shape suture with
Prolene lines were ligated strictly after lungs inflation.
Once the operating fields were inspected carefully and
found no observed bleeding, the thoracic incisions were
closed layer by layer. Normally, there was no the needs
of blood transfusions and closed thoracic drainages but
for the massive bleeding patients.
The whole operating times of OPOTTMIS for simple
CHD patients were approximate 20 minutes to 1 hour,
and the procedures and outcomes with the TEE surveil-
lance were shown as follows (Figure 3, Figure 4).
(4) Announcements
①Heparin used intra-operation aims to prevent blood
clotting and thrombosis and there was no protamine
sulfate used after the Occluder release. Twenty-four
hours after operation, a dose of 3.0 ~ 5.0 mg/kg aspirin
tablet was administrated to all the patients for anticoa-
gulation by oral once a day for about three to six
months. ②The OPOTTMIS patients were asked to per-
form TTE and ECG checks once a month within the
initial three months after operation, not to carry out
Figure 2 ASD, VSD and PDA Occluders used in the OPOTTMIS. (Made in Shanghai shape memory alloy material Ltd. Co., CN, No.:
20043770007). A: ASD Occluder; B: VSD Occluder; C: PDA Occluder. The Occluders are made from Nitinol materials.
Table 1 Occluder size select for OPOTTMIS.
Disease The experienced formulation
ASD Y = X + 4 ~ 6 (mm)
VSD Y = X + 4 ~ 6 (mm)
PDA Y = X + 2 ~ 4 (mm)
Y: size of Occluder; X: max diameter of defect tested by UCG.
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first month. Later, the patients must undertake TTE and
ECG checks once every three to six months. ③if there
were sever complications happened such as Occluder
migration even fall off, moderate or heavy residual
shunts, sever cardiac valve influence, haemolysis and
thrombosis, strokes, III° AVB and infective endocarditis
[5], they must be administered with the corresponding
rescue treatments.
Results
Among the consecutive 210 patients of CHD, 209 cases
were performed the OPOTTMIS operation successfully,
in which there were 92 cases of ASD, 63 cases of VSD
and 55 cases of PDA. In the ASD groups there was 1
case of mesh-shaped ASD concomitant with persistent
left superior vena cava (PLSVC) transferred to open sur-
gery under CPB and performed atrial septum resection
plus autologous pericardial patch repair and PLSVC
ligation, 2 cases with mild residual shunt and 1 case
with transitory II° AVB. In the VSD groups there were l
case of residual shunt, 1 case of II° AVB. In addition,
there were 2 patients (1 ASD and 1 VSD) with hae-
mothorax after operation for active bleeding at the car-
diac puncture sites rescued by secondary thoracic
exploration and haemostatic operation. In PDA groups
there were 1 case with residual shunt and 1 adult
patient with moderate-heavy pulmonary hypertension
died at 28 hours after operation due to pulmonary
hypertension crisis.
The mortality and complication incidence of OPOTT-
MIS operation within 72 hours were 0.5% and 4.8%,
respectively. Three days later after the operation, there
was no patient death. Particularly, the complication inci-
dences in ASD, VSD and PDA groups were 4.3% (4/92),
4.8% (3/63) and 3.6% (2/55) in sequence. Also, there
were no obvious complications of Occluder migration,
moderate or severe valve regurgitation, heart rupture,
IE, hemolysis and thrombosis, and strokes within peri-
operation.
Generally, the incisions of OPOTTMIS were 2.0 ~ 5.0
cm in length, and there were no blood transfusion and
mechanical ventilation using. Their hospitalized times
were 48 hours to 6 days and their total spending on
OPOTTMIS were 20,000 ~ 25,000 RMB (Ren-Min-Bi,
the Chinese currency). The three methods used pre-
sently for simple CHD therapy and their characteristics
were compared and shown as follows (Figure 5, table 5).
All the discharged 208 patients were followed up for 3
months to 4 years by the ways of telephone contact or/
and visits to outpatient department, moreover, their car-
diac function were in class I ~ II according to NYH
standard. Post-operation ECG and echo checks showed
that there were no III° AVB, no evident Occluder migra-
tion and fall off, no moderate or severe valve regurgita-
t i o n ,n os t r o k e s ,b u tf o r1V S Da n d1P D Aw i t hm i l d
residual shunts, 2 PDA with mild hearts expansion com-
pared to pre-operation.
Discussion
Although traditional open surgery is a main therapy to
CHD patients, it needs a large chest incision and CPB
with bad cosmetic effects because of large scar, severe
body injuries and many serious complications. At first,
Table 2 Applications of OPOTTMIS for simple CHD.
Disease OPOTTMIS applications
ASD ASD upper margin ≥ 4 mm, inferior margin ≥ 5 mm, with the defect marginal space to the annulus of MV ≥ 5 mm; Atrial septum
longitude > Occluder umbrella diameter within LA; ASD diameter < 38 mm; Secundum ostium with diplopore (one larger and the other
smaller).
VSD Peri-menbranous VSD; muscular VSD ≥ 4 mm; Inferior pulmonary trunk VSD with marginal space to the RCC ≥ 2 mm, without sever AV
prolapse and regurgitation; Muscular VSD affecting cardiac hemodynamic.
PDA Fistular PDA; Fenestrae PDA; Infundibular PDA; Left to right shunt PDA none malformation needing operation rectification; PDA diameter ≥
4 mm.
LA, left atrial; RCC, right coronary cusp; AV, aortic valve.
Table 3 Contraindications of OPOTTMIS for simple CHD.
Disease Respective contraindications Common contraindications
ASD Margin < 4 mm; Foramen primium defect with MV
cleavage; Mesh shaped ASD; SVC, IVC and CS ASD.
Sever right to the left shunt; Eisenmenger syndrome; Atrial thrombus; Complex
cardiac malformation; Uncontrolled pulmonary infection; Any pre-operation
serious infective diseases within one month (as ABE or systemic infection);
Malignant diseases with life expectancy < 3 years; Cannot get consent and
signature.
VSD Multiple small muscular VSD
PDA Dumbbell PDA; Combined with sever pulmonary
calcification, inflammation, or hypertension.
MV: mitral valve; ABE: acute bacterial endocarditis. SVC: superior vena cava; IVC: inferior vena cave; CS: coronary sinus.
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Occulder migration; Residual shunt; Bleeding; Arthythmia (Conduction block, Atrial fibrillation); Hemolysis; Blood
thrombus; Air embolus; Infection; Hemopneumothorax; Pericardial tamponade; Death.
TEE relative (approximately
1 ~ 3%)
Serious: Death; Esophagus and gastric perforation; Upper gastrointestinal hemorrhage; Arthythmia; Aspiration
pneumonitis.
Mild: Temporary air duct compression; Ventilation restriction; Descending aorta compression.
TEE, trans-esophageal echocardiography.
Figure 3 Procedures of OPOTTMIS. A: Through right atrium wall the outer sheath and guide probe across ASD; B: The inner sheath and the
implanted and released Occluder with safe wirestraddled on the edges of ASD; C: Through the right ventricular wall the implanted and released
Occluder straddled on the edges of VSD; D: Through the main pulmonary wall the implanted and released Occluder straddled on the edges of
PDA; Device also referred as Occluder; Safe wire (gross silk suture) also referred as retrieval wire.
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for palliative treatment in complex CHD may be initial
sprout of Hybrid method. With Amplatzer Occluder
used widely, interventional therapy to CHD patients
with left to right shunts has got into new eras [26-30].
Meanwhile with improvements of the intervention
equipments and operating skills the therapeutic strategy
of CHD has been changed. As an integration of physi-
cian intervention and surgery techniques, hybrid
approach has gradually grown into a mature operation
with various advantages from an initial idea and a trial
on simplex, complex or severe CHD therapy. Compared
to surgery and physician intervention, hybrid approach
is prompt and convenient with several advantages of
applicability, maneuverability, flexibility and reciprocal
to problems that cannot be settled by themselves alone,
because it can reduce the risk and trauma of surgery,
avoiding X-ray and catheter damages of intervention,
increasing the operating efficacy, and decreasing their
respective complications [31-36].
Why the devices were delivered via chest wall inci-
sions rather than transvenous approach in the operation
of OPOTTMIS? Because these incisions could supply
convenient, short and straightforward operating path-
ways approaching to the heart puncture sites through
which Occluders could reach the defects directly. More-
over, large delivery shealth and Occluders can pass
through them for large defect blocking. As we knew
that physician intervention occlusion on adult and large
defect CHD patients may appear vascular injuries and
cardiac structure damages because of angiosclerosis, pul-
monary hypertension and tissue degeneration, while
infants and children exposed to X-ray may cause poten-
tial marrow damages and malignant diseases. In addi-
tion, allergic patients with contrast agent are
incompatible for intervention treatment. When the
emergency events take place during physician interven-
tion procedures such as Occluder migration or fall off,
or the vascular and inner cardiac structures damaged
or/and twisted by the long slender catheter or/and guide
wire, it must be transferred to the open surgery. Also,
because of the long distance and time of transportation
between catheter room and operation room, the transit
valuable opportunities to rescue these patients may be
wasted. Now days, CPB is still indispensable to CHD
therapy in most methods of MICS (minimally invasive
Figure 4 OPOTTMIS outcomes of pre-and post-operation with TEE surveillance. TEE images showing the abnormal blood stream
disappeared post-OPOTTMIS.
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surgery) and Robotic System cardiac surgery. However,
long learning curve and high cost are need to these
methods so that their wide applications in the domestic
are restrained [6-10].
The OPOTTMIS operation represented the humanis-
tic and patient-oriented therapeutic spirits with short
and direct pathway, without CPB interfering with phy-
siological internal environment, avoiding potential trans-
catheter and guide wire injuries to the pathway vascular
and cardiac inner structures such as valves, chordaes,
papillary muscles, conductio nb l u n t s ,e t c .A l s oi tc a n
reduce skin scars with a favorable cosmetic outcomes,
lower the spending compared to other methods, avoid
X-ray damages to medical personnel and patients, as
reported that X-ray may lead to chromosome and DNA
damages, infertility being genitical gland injuries, even
myelosuppression, leukaemia and other cancers,
especially to children, adolescents and the child-bearing
women [33-38].
The operating and Occluder release must be moni-
tored with real-time ECG and TEE checks to avoid III°
AVB and ensure the device at an appropriate position,
which is key factor of success for OPOTTMIS [24].
Adequate inner cardiac anatomy knowledge and skilled
TEE manipulating techniques are necessary for ultraso-
nic specialist. The relations of the delivery system,
Occluder, the adjacent atrioventricular valves, coronary
sinus and defect edges should be seen clearly during the
operation from different planes and different angles.
The release position of Occluders (especially, eccentric
Occluders) must be adjusted to avoid inner cardiac
structure injuries such as valves, conductive bundles,
chordaes, papillary muscles and endocardium. At last,
once the Occluder waist straddled on the defect edges
and clamped firmly, with its umbrella lobes in an
Figure 5 Incisions comparison of OPOTTMIS and traditional open surgery (TOS). A: ASD; B: VSD; C: PDA; D: TOS.
Guo et al. Journal of Cardiothoracic Surgery 2011, 6:48
http://www.cardiothoracicsurgery.org/content/6/1/48
Page 7 of 9appropriate position and bearing steady strength, with-
out residual shunts and evident influences to the adja-
cent inner cardiac structures, the “safe wire” stitched on
the Occluder was cut off and removed.
The good advantages of OPOTTMIS [21-24] were
shown as: ①Improved the security and accuracy of occlu-
sion: Using short, large and straightforward delivery sys-
tem instead of long, slender and curved sheath in
physician intervention made operating procedures con-
trolled freely. Therefore OPOTTMIS could reduce the
risk of cardiac structure damages and myocardium per-
forations. ②Wider indications and high success rate of
occlusion: OPOTTMIS was applicable to several special
defects puzzling physician intervention such as large ASD
(diameter > 30 mm), edge deficient ASD, lager VSD,
eccentric VSD and larger PDA. Since the pathway of
OPOTTMIS was short so the direction and angle of deliv-
ery systems could be controlled and regulated freely. Lager
Occluder within wide sheath could supply consistent suffi-
cient clamp strength on the defect edges, reduce device
fall off and residual leakages, and improve the success rate
of OPOTTMIS compared to physician intervention.
③Without vascular damages: Because its pathway doesn’t
go through vascular thus without vascular damages,
OPOTTMIS also could be used in children with low body
weight and small vascular. ④Without large chest incision
and CPB using: OPPOTTMIS is minimal invasion with
mild postoperative pain, fast recovery and short hospita-
lized time (2 - 6 days). ⑤Convenient transform to open
surgery and high security:T h eO P O T T M I Sw a sp e r -
formed in the operating room, once emergency events
happened, rescued measures or transform to open surgery
could be administered immediately when needed. ⑥Short
operating time: Normally, OPPOTTMIS operating times
were 20 minutes to 1 hour. ⑦Excellent cosmetic effect:
Small and low chest wall incisions without drainage tubes
were used in OPOTTMIS with minimal dermatic scar and
good cosmetic effect, especially for children and young
women. ⑧Without X-ray damages. ⑨Low expenses: Gen-
erally, compared to the traditional open surgery and physi-
cian intervention methods, the spending of the
OPOTTMIS was lower with a total sum of RMB 20,000 ~
25,000 due to without blood transfusion and respiratory
machine using.
Conclusions
OPOTTMIS is a safe, feasible, effective and appropriate
option for selected simple CHD (ASD, VSD and PDA)
patients with good advantages of straightforward operat-
ing procedures apt to be learned and mastered, with
wider indications, cosmetic incisions, mild post-opera-
tion pains, shorter hospitalized time, less hospital
charges, without X-ray damages to the patients and
medical staff, patient willing acceptance, and a favorable
short term efficacy. However the long term outcomes
and influences to heart functions should be studied in
the future.
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